Methionine restriction attenuates the migration and invasion of gastric cancer cells by inhibiting nuclear p65 translocation through TRIM47
Author:
Xin Lin1ORCID, Yuan Yi-Wu1, Liu Chen-Xi2, Sheng Jie1, Zhou Qi1, Liu Zhi-Yang1, Yue Zhen-Qi1, Zeng Fei1
Affiliation:
1. Department of General Surgery , The Second Affiliated Hospital of Nanchang University , No. 1 Minde Road , Nanchang 330006 , Jiangxi Province , China 2. Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry , Nanchang University , Nanchang , Jiangxi Province , China
Abstract
Abstract
The prevention and treatment of gastric cancer has been the focus and difficulty of medical research. We aimed to explore the mechanism of inhibiting migration and invasion of gastric cancer cells by methionine restriction (MR). The human gastric cancer cell lines AGS and MKN45 cultured with complete medium (CM) or medium without methionine were used for in vitro experiments. MKN45 cells were injected tail vein into BALB/c nude mice and then fed with normal diet or methionine diet for in vivo experiments. MR treatment decreased cell migration and invasion, increased E-cadherin expression, decreased N-cadherin and p-p65 expressions, and inhibited nuclear p65 translocation of AGS and MKN45 cells when compared with CM group. MR treatment increased IκBα protein expression and protein stability, and decreased IκBα protein ubiquitination level and TRIM47 expression. TRIM47 interacted with IκBα protein, and overexpression of TRIM47 reversed the regulatory effects of MR. TRIM47 promoted lung metastasis formation and partially attenuated the effect of MR on metastasis formation in vivo compared to normal diet group mice. MR reduces TRIM47 expression, leads to the degradation of IκBα, and then inhibits the translocation of nuclear p65 and the migration and invasion of gastric cancer cells.
Funder
The National Natural Science Foundation of China Jiangxi Province Academic and Technical Leaders Training Program for Major Disciplines Science and Technology Project of Jiangxi Provincial Health Commission The National Natural Science Foundation
Publisher
Walter de Gruyter GmbH
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference25 articles.
1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., and Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J. Clin. 68: 394–424, https://doi.org/10.3322/caac.21492. 2. Chaturvedi, S., Hoffman, R.M., and Bertino, J.R. (2018). Exploiting methionine restriction for cancer treatment. Biochem. Pharmacol. 154: 170–173, https://doi.org/10.1016/j.bcp.2018.05.003. 3. Chen, J.X., Xu, D., Cao, J.W., Zuo, L., Han, Z.T., Tian, Y.J., Chu, C.M., Zhou, W., Pan, X.W., and Cui, X.G. (2021). TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination. Cancer Cell Int. 21: 129, https://doi.org/10.1186/s12935-021-01831-0. 4. Dai, W., Wang, J., Wang, Z., Xiao, Y., Li, J., Hong, L., Pei, M., Zhang, J., Yang, P., Wu, X., et al.. (2021). Comprehensive analysis of the prognostic values of the TRIM family in hepatocellular carcinoma. Front. Oncol. 11: 767644, https://doi.org/10.3389/fonc.2021.767644. 5. Durand, J.K. and Baldwin, A.S. (2017). Targeting IKK and NF-κB for therapy. Adv. Protein Chem. Struct. Biol. 107: 77–115, https://doi.org/10.1016/bs.apcsb.2016.11.006.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|